Alcon Inc. (ALC) PT Raised to $110 at Baird

Go back to Alcon Inc. (ALC) PT Raised to $110 at Baird

CFRA Reiterates Buy Rating on Alcon Inc. (ALC:SW) (ALC)

August 26, 2024 6:49 AM EDT

CFRA analyst Wan Nurhayati reiterated a Buy rating and CHF87.00 price target on Alcon Inc. (ALC:SW) (NYSE: ALC).

The analyst comments "We keep our target price of CHF87, implying a 2024 P/E of 34x or 2025 P/E of 30x, in line with... More

Alcon Inc. (ALC) PT Raised to $110 at Oppenheimer

August 22, 2024 7:07 AM EDT

Oppenheimer analyst Steve Lichtman raised the price target on Alcon Inc. (NYSE: ALC) to $110.00 (from $103.00) while maintaining a Outperform rating.

The analyst comments "Alcon's 2Q24 saw slightly lower than expected sales, underlying gross/operating margin exceeding expectations, and continued progress on the pipeline.... More

Alcon Inc. (ALC) PT Raised to $110 at Mizuho

August 22, 2024 6:37 AM EDT

Mizuho analyst Anthony Petrone raised the price target on Alcon Inc. (NYSE: ALC) to $110.00 (from $105.00) while maintaining a Outperform rating.

The analyst comments "Key 2Q call findings: 1) contact lens price + share gains continued in 2Q'24 with ALC growing +9% cc versus +6% for underlying market... More

Alcon Inc. (ALC) PT Raised to $105 at Wells Fargo

August 22, 2024 5:04 AM EDT

Wells Fargo analyst Larry Biegelsen raised the price target on Alcon Inc. (NYSE: ALC) to $105.00 (from $94.00) while maintaining a Overweight rating.

The analyst comments "Q2 margin shortfall due to inventory provisions. Q2 net product sales core GM of 62.0% came in below... More

Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF84.30 at JPMorgan

August 22, 2024 2:19 AM EDT

JPMorgan analyst David Adlington lowered the price target on Alcon Inc. (ALC:SW) (NYSE: ALC) to CHF84.30 (from CHF88.90) while maintaining a Overweight rating.... More

Alcon Inc. (ALC) PT Raised to $98 at BTIG

August 21, 2024 11:39 AM EDT

BTIG analyst Ryan Zimmerman raised the price target on Alcon Inc. (NYSE: ALC) to $98.00 (from $96.00) while maintaining a Buy rating.

The analyst comments "As noted previously (here), ALC delivered ~6.0% xFx growth with Surgical growing 6% xFx and Vision Care growing 6% xFx. Core EPS was above expectations at $0.01 with GMs and OMs both coming... More

Stifel Reiterates Buy Rating on Alcon Inc. (ALC)

August 21, 2024 6:40 AM EDT

Stifel analyst Tom Stephan reiterated a Buy rating and $100.00 price target on Alcon Inc. (NYSE: ALC).

The analyst comments "The quarter--notably on the top-line--was maybe a little noisier than investors were anticipating after generally solid YTD momentum. Still, margins werent as... More

Citi Reiterates Buy Rating on Alcon Inc. (ALC:SW) (ALC)

August 21, 2024 2:13 AM EDT

Citi analyst Veronika Dubajova reiterated a Buy rating and CHF103.00 price target on Alcon Inc. (ALC:SW) (NYSE: ALC).

The analyst comments: "Alcon reported 2Q24 ccy sales growth c.100bps below VisibleAlpha consensus (c.80bps below Citi), with Vision Care... More

Alcon (ALC) Tops Q2 EPS by 1c; maintains guidance

August 20, 2024 4:32 PM EDT

Alcon (NYSE: ALC) reported Q2 EPS of $0.74, $0.01 better than the analyst estimate of $0.73. Revenue for the quarter came in at $2.48 billion versus the consensus estimate of $2.53 billion.

GUIDANCE:

Alcon sees FY2024 EPS of $3.00-$3.10, versus the consensus of $3.06. Alcon sees... More